The information in the literature on squamous cell and adenosquamous carcinomas of the gallbladder is highly limited. In this study, 606 resected invasive gallbladder carcinoma cases were analyzed. Squamous differentiation was identified in 41 cases (7%). Those without any identifiable glandular-type invasive component were classified as pure squamous cell carcinomas (8 cases) and those with the squamous component constituting 25-99% of the tumors were classified as adenosquamous carcinomas (26 cases) and included into the analysis. The remaining 7 that had o25% squamous component were classified as adenocarcinoma with focal squamous change and excluded. The clinicopathological characteristics of adenosquamous carcinoma/squamous cell carcinomas were documented and contrasted with that of ordinary gallbladder adenocarcinomas. The average patient age was 65 years (range 26-81); female/male ratio, 3.8. In only 13%, there was a preoperative clinical suspicion of malignancy. Grossly, 58% presented as thickening and hardening of the wall and 6% were polypoid. In 12%, mucosa adjacent to the tumor revealed squamous metaplasia. All pure squamous cell carcinomas had prominent keratinization. Giant cells and tumor-infiltrating eosinophils were observed in 29 and 51% of the squamous cell carcinomas/adenosquamous carcinomas versus 10% (P ¼ 0.02) and 6% (P ¼ 0.001) in gallbladder adenocarcinomas, respectively. All but three cases had 'advanced' (pT2 and above) carcinomas. Follow-up was available in 31 patients: 25 died of disease (median ¼ 5 months, range 0-20), and 6 were alive (median ¼ 64 months, range 5-112.5). The survival of patients with squamous cell carcinomas/adenosquamous carcinomas was significantly worse than that of gallbladder adenocarcinomas (P ¼ 0.003), and this adverse prognosis persisted when compared with stage-matched advanced gallbladder adenocarcinoma cases (median ¼ 11.4 months, P ¼ 0.01). In conclusion, squamous differentiation was noted in 7% of gallbladder carcinomas. The incidence of adenosquamous carcinoma (defined as 25-99% of the tumor being squamous) was 4%, and that of pure squamous cell carcinoma (without any documented invasive glandular component) was 1%. Pure squamous cell carcinomas often showed prominent keratinization. The overall prognosis of adenosquamous carcinoma/squamous cell carcinoma appears to be even worse than that of ordinary adenocarcinomas. Most patients died within a few months; however, those few who were alive beyond 2 years in this cohort experienced long-term survival.
Gallbladder cancer is the most frequent neoplasm of the biliary tract with a clear predominance in the female population (2-6 times more frequent than in men). [1] [2] [3] [4] Its prevalence is widely variable, depending on the population studied: for example, in the United States, its frequency is 1.43/100 000 inhabitants, whereas in countries like Chile, this figure climbs up to 17.8/100 000 inhabitants. 3, 5, 6 At the same time, variations in its prevalence have been reported for both different indigenous groups and different geographical areas in the same country; facts that suggest important genetic and environmental influences on the development of the disease.
Adenocarcinomas are by far the most frequent histological subtype of the malignant gallbladder neoplasms, representing approximately 90-95% of all cases. 1 In contrast, squamous cell or 'epidermoid' carcinomas and adenosquamous carcinomas are rare. 1, 7, 8 The literature on these histologic types has been highly limited, mostly represented as individual case reports or analysis of small case series of a handful of cases. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Furthermore, there has been no uniform definition for these tumors, with different authors employing different criteria: some regarded any squamous differentiation as a qualification for adenosquamous carcinoma even if it is a very small component of the tumor, and at the same time, others seemed to have included cases with substantial adenocarcinoma component into squamous cell carcinoma category. 9, 13, 14, [21] [22] [23] These definitional differences may partly be responsible for the variations in reported incidence of these tumors, which ranges from 1 to 12%. 14, 18, [24] [25] [26] [27] [28] Although the limited nature of the data and the definitional variations precluded proper characterization of these tumors, some common threads could be observed: it had been speculated that adenosquamous carcinomas/ squamous cell carcinomas are at least as aggressive as ordinary gallbladder adenocarcinomas. 9, 11, [13] [14] [15] 23, 29 It has been observed that the squamous component of gallbladder carcinomas proliferates at a higher rate than the glandular component; 14 however, despite their high proliferation rate, these tumors appeared to less frequently present with lymph node metastasis than gallbladder adenocarcinomas. 21 Their aggressive biological behavior has been attributed to their potential for direct extension and early invasion into the liver and neighboring organs, such as the stomach, duodenum and transverse colon. 9, 21, 23, 29, 30 The biology of carcinomas with squamous differentiation is intriguing. When all organs and sites are considered together, one might conclude that squamous cell carcinomas in general have a better prognosis than adenocarcinomas, although others would argue that this is related to the more superficial nature of squamous cancers occurring in accessible sites like skin, head and neck, gynecologic and genitourinary tracts, which are amenable to early diagnosis and easier surgical intervention. 31 On the other hand, even advanced squamous cell carcinomas of these sites appear to have somewhat better prognosis than adenocarcinomas. 32 This might give the impression that squamous cell carcinomas are slow-growing neoplasia when compared with malignancies of glandular type. However, this certainly does not seem to hold true for 'metaplastic' type squamous cell and adenosquamous carcinomas arising in glandular organs where adenocarcinomas are far more common. For example, in the breast and the pancreas, carcinomas with squamous differentiation have been shown to be aggressive neoplasia with a prognosis even worse than that of conventional adenocarcinomas of these respective sites. [33] [34] [35] [36] Whether this is also valid for squamous cell carcinoma/adenosquamous carcinoma of gallbladder or not has yet to be proven.
The aims of this study were to: (1) determine the frequency of squamous differentiation in the gallbladder; (2) provide more specific definitions for adenosquamous carcinoma and squamous cell carcinoma; (3) elucidate the clinicopathological characteristics of these tumors defined by these more specific criteria; and (4) determine the prognoses of these tumors and compare them with that of gallbladder adenocarcinoma. For this purpose, 606 gallbladder carcinomas obtained from different geographic regions were analyzed in detail retrospectively.
Materials and methods

Cases
Pathology material (reports and slides) from 606 consecutive invasive carcinomas of gallbladder identified in the authors' institutional files were retrieved and evaluated. Of these, 471 were from a high-gallbladder cancer incidence region (Hernán Henríquez Aravena Hospita, Universite de la Frontera, Temuco, Chile) and 135 from North America (Wayne State University, Detroit, MI, USA, and Emory University, Atlanta, GA, USA) where gallbladder cancer incidence is relatively low. In each case, a detailed analysis of the tumor was performed to determine the amount of squamous and glandular components. An average of 12 tumor slides per case was evaluated. Pure squamous cell carcinomas were entirely submitted and evaluated.
Definitions
Squamous differentiation
In the invasive carcinomas, the presence of any areas with squamous features, as defined and well characterized in other organs, was recognized and recorded as squamous differentiation. None of the cases in this study had features that could be classified as 'adenoacanthoma', and none of the squamous areas had the features of benign squamoid morules that can be seen in other neoplasms including 'adenomas' of gallbladder. In all cases, the squamous cells exhibited either or both cytologic atypia and/or dyskeratosis characteristic of malignant squamous cells.
Pure squamous cell carcinoma
Those invasive carcinomas composed exclusively of squamous differentiation without any recognizable invasive glandular component were classified as pure squamous cell carcinomas. This definition is very similar to that employed in urinary bladder. Presence of glandular dysplasia/carcinoma in situ was not considered a criterion of exclusion, as long as there were no invasive glandular elements.
Adenosquamous carcinoma
If the squamous component of the tumor constituted 25-99% of the tumor, it was classified as adenosquamous carcinoma. The '25%' cutoff was selected arbitrarily as has been done for mixed differentiation cancers of other organs including the pancreas, where 'mixed' carcinomas have been well defined. 37 Carcinoma with focal squamous change Cases in which the squamous component constituted o25% of the tumor were placed in this category and excluded from the analysis.
Histopathological Analysis
After the study cohort was identified based on the definitions provided above, it was then further analyzed for other morphological patterns and variations including amount of keratin, clear cell change, sarcomatoid change, goblet cells, sebaceous differentiation, cyst formation and necrosis. Association with an intracholecystic papillary tubular neoplasm, if present, was also duly recorded. Intracholecystic papillary tubular neoplasm is an unifying term the authors employ [38] [39] [40] for all the tumoral intraepithelial neoplasms that are 41 cm, occurring in the gallbladder including what World Health Organization 1 refers as 'adenoma' and 'intracystic papillary neoplasm' (papillary adenomas, and adenocarcinomas). In other words, these are gallbladder counterparts of pancreatic intraductal papillary mucinous neoplasms, 1 biliary intraductal papillary neoplasms, 1 and intraampullary papillary tubular neoplasms. 1, [38] [39] [40] [41] In addition, both the study group and a control group (composed of 50 cases randomly selected from the excluded cases without any squamous differentiation) were analyzed for the following parameters: histological grade (well, moderate or poor, as determined by conventional approach), vascular invasion, perineural invasion, tumor giant cells and the amount of 'tumor-infiltrating' inflammatory cells (eosinophils and lymphocytes) as defined in other studies; [42] [43] [44] ie, those associated preferentially with the tumor (in the vicinity of the tumor, in between the tumor cells or immediately adjacent to tumor cell clusters). The inflammation was semiquantitatively scored as 0 ¼ none, 1 ¼ minimal, 2 ¼ moderate and 3 ¼ marked, and subsequently grouped for comparison purposes as negligible (0 and 1) and significant (2 and 3).
Where applicable, statistical analysis was performed using Student's t-test for comparison.
Clinical Parameters
Information on the patients' gender and age as well as the clinical outcome were obtained through surgical pathology reports, patient's charts, from patient's primary physicians or Surveillance Epidemiology End Results (SEER) database in the United States, and from the Civil Registry as well as the databases of death certificates in the IT Department of the Head Office of the South Araucanía Health Service, in Chile. The patients who died within the first 30 days of the postoperative period were excluded from the survival analysis.
Survival Analysis
The survival analysis was performed using the statistical software Epi-info 6.0 and Stata 9.0. An exploratory analysis was performed and descriptive statistics subsequently applied with calculation of averages and s.d., medians and extreme values for continuous variables, calculation of percentages for category variables and Kaplan-Meier actuarial survival curves. Then, analytical statistics was applied, using t-test and analysis of variance (ANOVA) for continuous variables, Pearson's w 2 and Fisher's exact test for category variables and a log-rank test (CoxMantel) for survival comparisons. In addition to the comparison with the entire gallbladder adenocarcinoma group, the survival of adenosquamous carcinoma/squamous cell carcinoma was also separately compared with the advanced (pT2, pT3 and pT4) subset of gallbladder adenocarcinoma cases in order to eliminate the potential bias due to early carcinomas (pT1), which are common in the Temuco population.
Ethical Aspects
Helsinki principles were observed in the conduct of this study. In addition, the confidentiality of each patient's data was assured via their codification. The studies were performed in accordance with the institutional review board requirements.
Results
Incidence and Clinical Features
Squamous differentiation was identified in 41 of 606 invasive gallbladder carcinomas (7%). Of these, 26 cases (4%) were adenosquamous carcinomas (25-99% of the tumor was squamous), and 8 (1%) were pure squamous cell carcinomas. The remaining 7 with o25% squamous component were classified as adenocarcinomas with focal squamous change and excluded.
The patients were 27 females and 7 males (female/ male ratio was 3.8, same as in gallbladder adenocarcinoma). Mean age of the patients was 65 years (versus 64 in gallbladder adenocarcinoma) with a range of 26-81 years. In only 13%, there was a preoperative clinical suspicion of malignancy.
Pathological Features
Macroscopic features
The median and average tumor sizes were 2.5 and 3.1 cm, respectively (versus 2.4 and 2.7 in the control group of gallbladder adenocarcinoma; P ¼ 0.42). In 58%, the tumor was not apparent even under macroscopic examination; carcinoma formed plaque-like mural thickening and induration indistinguishable from cholecystitis. In the remainder, there were irregular and variable amounts of nodular arrangements ( Figure 1 ). The mucosal aspect of the tumor was ulcerated and hemorrhagic in some cases. Two cases had friable papillary/polypoid projections ( Figure 1 ) consistent with an intracholecystic papillary tubular component. Of the tumors, 39% were located in the fundus, 15% in the lower third, 15% in the body and 31% had invaded more than one gallbladder segment. The exact incidence of gallstones could not be determined because in many cases, the gallstones had been removed by the surgeons as requested by the patients and this occurrence was not documented (and could not be verified accurately).
Microscopic features
A total of 65% (17/26) of ASCs had focal keratinization, whereas others were poorly differentiated; however, 88% (7/8) of pure squamous cell carcinomas had substantial keratinization including pearl formation and dyskeratotic cells (Figure 2 ). Four cases (12%) revealed squamous metaplasia in the adjacent mucosa (Figure 3) . Metaplastic foci had variable degrees of atypia. Six cases revealed focal sarcomatoid appearance with often pleomorphic spindle cells (Figure 4) . Five displayed comedolike central necrosis in the large infiltrating squamous nests. Focal clear cell change was observed in five cases ( Figure 5) , and in one of these the tumor exhibited renal cell carcinoma-like pattern with alveolar growth and delicate vasculature. Interestingly, in three cases there was a peculiar microcystic change with accumulation of proteinaceouslike material within the cystic spaces ( Figure 6 ). Sebaceous differentiation (Figure 7 ) and goblet cell change ( Figure 8 ) were highly uncommon, each noted as focal findings in singular cases.
Invasive glandular components seen in the adenosquamous carcinoma cases displayed a spectrum of patterns similar to that seen in gallbladder adenocarcinomas.
In two cases, there was intracholecystic papillary tubular neoplasm. 1, [38] [39] [40] Squamous carcinoma cells were seen within the head of the polyp in these cases ( Figure 9) .
Bizarre, pleomorphic tumor giant cells ( Figure 4 ) were identified in 29% of adenosquamous carcinomas/squamous cell carcinomas, whereas they were noted in only 10% of the gallbladder adenocarcinoma control group (P ¼ 0.02).
Tumor-infiltrating eosinophils ( Figure  10 ) were also more common in pure squamous cell carcinomas (51% had significant-score 2 and 3-eosinophils) than in the gallbladder adenocarcinoma control group (only 6% had significant eosinophils; P ¼ 0.001). Tumor-infiltrating lymphocytes were also more common in pure squamous cell carcinomas than in the gallbladder adenocarcinoma control group; however, the difference was not significant (50 versus 34%).
The incidence of vascular and perineural invasions was 76 and 32%, respectively, versus 72 and 48% in gallbladder adenocarcinoma control group (P ¼ 0.21 and P ¼ 0.22, respectively). The majority were advanced carcinomas, most with invasion beyond the muscularis (T1b, 3 cases (9%); T2, 8 cases (24%); T3, 23 cases (68%); T3: 23 cases (68%) versus T3: 251 cases (49%) in the gallbladder adenocarcinoma control group; P ¼ 0.03). Also, 24% (8/34) had lymph node metastasis (6 adenosquamous carcinomas and 2 pure squamous cell carcinomas). Of seven lymph nodes available for our examination, five showed squamous areas (three ASCs and two SCCs; Figure 11 ).
Clinical course
Follow-up was available in 31 patients with adenosquamous carcinomas/squamous cell carcinomas, 25 of whom died of disease soon after diagnosis (median ¼ 5, range 1-20 months) and 6 were alive (median ¼ 64, range 5-112.5 months). When compared with the all-comers of gallbladder adenocarcinomas, (n ¼ 572) including the early (muscle confined) gallbladder cancers that are relatively common in the Temuco database, the survival of patients with squamous cell carcinomas/adenosquamous carcinomas was significantly worse than that of gallbladder adenocarcinomas (median ¼ 4 vs 12; P ¼ 0.003; Figure 12 ). More importantly, this adverse prognosis persisted when compared with stage-matched 'advanced (pT2, pT3 and pT4)' gallbladder adenocarcinoma cases (n ¼ 452) who had a median survival of 11.4 months (P ¼ 0.01) as well as with individual stage groups with the exception of T3, which did not reach the same statistical significance (P ¼ 0.09, Table 2 ). The results are summarized in Tables 1 and 2 .
Discussion
Squamous differentiation is rather uncommon in the gallbladder. In this study of 606 invasive carcinomas, which represents the largest cohort to be analyzed for this purpose to date, squamous differentiation was detected in 7% of the cases. This figure varied significantly in the literature, ranging from 1 to 12%, [24] [25] [26] [27] presumably mostly due to the definitional differences. Our study demonstrates that pure squamous cell carcinomas, which we defined as invasive carcinomas composed entirely of squamous differentiation, are very uncommon, constituting only 1% of the cases. Rather, squamous differentiation in the gallbladder is seen mostly as a secondary component in association with conventional adenocarcinomas. 9, 13, 14, 21, 23, 25, 29, 45, 46 This focal squamous differentiation can vary in amount from very minimal, presumably with no (or negligible) clinical/biological significance, to extensive. We employed the arbitrary cutoff of 'o25%' to determine the negligibility of this secondary differentiation, as has been done for the mixed differentiation carcinomas of other organs, and classified such cases as adenocarcinoma with focal squamous change (1% of the cases), and reserved the diagnosis of adenosquamous carcinoma for only those that have 25-99% of the tumor showing squamous differentiation (4% of gallbladder carcinomas). In order to determine the clinicopathological significance and associations of squamous differentiation in gallbladder carcinomas, we analyzed squamous cell carcinomas/adenosquamous carcinomas together and disregarded the cases with 'focal squamous change' from the analysis. The clinical presentation of adenosquamous carcinoma/squamous cell carcinoma group in this study did not seem to be too different than ordinary gallbladder adenocarcinomas, and the impression in the literature is in accordance with this observation. 9, [13] [14] [15] 21, 23, 25, 29 The patients are in their mid 60s-the youngest patient in this study was 26-and it occurs predominantly in females (F/M ¼ 3.8), similar to gallbladder adenocarcinomas (F/ M ¼ 3.8). As is the case for most gallbladder carcinomas, preoperatively, most patients (485%) are not suspected to have cancer, and instead undergo cholecystectomy with the diagnosis of cholecystitis. The majority of the tumors (B40%) are located in the fundus, whereas the remainder involve the neck, body or the entire organ diffusely. The tumors appear to be slightly larger at presentation than ordinary gallbladder adenocarcinomas, but the difference was not statistically significant in this study (mean, 3.1 versus 2.7; P ¼ 0.42).
Microscopically, one distinctive aspect of pure squamous cell carcinomas was that almost all (7/8) had substantial keratinization, showing abundant keratohyaline pearls, dyskeratotic cells and central deposition of dense keratin material within the infiltrative nests (Figure 2) . Additionally, the presence of peritumoral eosinophils, which is a rather unusual and focal finding in otherwise ordinary gallbladder adenocarcinomas, was quite prominent in half of the squamous cell carcinomas. This may be interesting to note, because peritumoral eosinophilia ( Figure 10 ) has been found to be rather common in squamous cell carcinomas, in particular, of the head and neck region, and some chemotactic factors and biologic/prognostic associations have also been implicated. 47 Unfortunately, the number of cases were too small in this study to determine such similar association, if there was one, in gallbladder.
Although squamous cell carcinomas appeared to be rather well differentiated, with common and prominent keratinization (Figure 2) , the squamous component of adenosquamous carcinomas were often of the poorly differentiated kind. In fact, adenosquamous carcinomas commonly displayed histologic signs of aggressiveness and high-grade features. Comedo-like necrosis ( Figure 5 ) was noted in the infiltrative nests in multiple cases. More importantly, tumor giant cells (Figure 4 ), seen in a third of the cases, was significantly more common than in the control group (P ¼ 0.02), and sarcomatoid change (Figure 4 ) was also seen in 20%. This, however, may not be surprising as squamous differentiation in carcinomas of glandular organs often occur as a result of 'metaplastic' change, which often occurs as a part of 'dedifferentiation'. 33, 35, 36, 48 For example, in the breast, squamous differentiation is often a part of sarcomatoid carcinomas and highgrade transformation, and regarded under the category of 'metaplastic' carcinomas. 36, 48, 49 On the other hand, although many gallbladder adenosquamous carcinomas/squamous cell carcinomas showed highgrade histologic features, it may also be important to note that focal aberrant differentiation toward other cell lineages such as sebaceous differentiation and goblet cells (Figures 7 and 8) were also occasionally encountered in these tumors. In fact, in some cases, a peculiar microcystic pattern of a well-differentiated carcinoma was exhibited ( Figure 6 ).
Along with commonly higher-grade appearance especially of the adenosquamous carcinoma cases, the adenosquamous carcinoma/squamous cell carcinoma group also shows trends for being locally advanced (pT2, pT3 and pT4) carcinomas. The tumors were slightly larger in average size at presentation, although the difference did not reach statistical significance. More importantly, although two-thirds of adenosquamous carcinoma/squamous cell carcinoma cases were pT3 in our study, only half of the gallbladder adenocarcinomas were pT3s (P ¼ 0.03), the rest were lower-stage tumors. That adenosquamous carcinomas/squamous cell carcinomas have a tendency to be more locally spread at diagnosis, especially to liver, has also been noted in the literature in some studies. 9, 21, 23, 29, 30 On the other hand, some studies have noted (in very limited data) that although these tumors may have a higher tendency to invade to liver, the incidence of lymph node metastasis was lower than ordinary gallbladder adenocarcinomas. Unfortunately, we believe the data are too limited to determine this; the information in lymph node staging in our study was also not accurate enough to make this determination either.
The etiopathogenesis of adenosquamous carcinoma/squamous cell carcinoma and whether it differs from that of gallbladder adenocarcinoma is difficult to determine. In general, chemical agents and irritants are known to induce squamous carcinogenesis, 10, 50 but although this has been established for organs that normally have squamous epithelium, the causes of squamous differentiation in carcinomas of glandular organs have been much less well understood, with the exception of the well-known parasitic association in urinary bladder. 51 In the gallbladder, some adenosquamous carcinomas/squamous cell carcinomas have been noted in association with parasitic infections as well; 52 however, most seem not to be related to parasites. Among our patients, none was known to have biliary flukes. It is conceivable that gallstones, which have a wellestablished role in gallbladder carcinogenesis, would possibly have a role in adenosquamous carcinomas/squamous cell carcinomas as well. Unfortunately, we do not have accurate information on the gallstone status of some of our patients, and therefore we cannot verify this association. No other known risk factors could be identified; our patients did not have primary sclerosing cholangitis or documented anomalous union or any syndromes that are known to be risk factors for gallbladder adenocarcinoma. In the literature, rare adenosquamous carcinomas/squamous cell carcinomas occurring in association with gallstones and parasitic infection have been documented, mostly as individual case reports, suggesting that this association may not be any different than that of ordinary gallbladder adenocarcinomas. 8 It may be interesting to note that B12% of the cases in our study had squamous changes in the adjacent mucosa, indicating that whatever was the instigator was also presumably leading to early mucosal changes first, followed by the dysplasia-carcinoma sequence. Also, interestingly, two cases arose in association with a mass-forming preinvasive neoplasm, which we call intracholecystic papillary neoplasm. 38 In our experience, this adenomacarcinoma pathway is responsible for B10% of the invasive carcinomas, 38 and therefore it would not be surprising that 2 of the 34 adenosquamous carcinoma/squamous cell carcinoma cases also arose in association with this pathway.
Unlike the squamous cell carcinomas arising in normally squamous-lined organs, adenosquamous carcinomas/squamous cell carcinomas of gallbladder appear to be highly aggressive neoplasia, similar to those arising in other glandular organs such as pancreas and breast, with a prognosis at least as dismal, and possible even worse than that of the ordinary gallbladder adenocarcinoma. Most of our patients died within a few months, with a median survival of 5 months, which is incomparably worse than when all gallbladder adenocarcinomas are considered together (including those early carcinomas encountered in the Temuco population); however, it was also significantly more aggressive even when compared with the control group of randomly selected 'advanced (pT2, pT3 and pT4)' gallbladder adenocarcinoma cases (with median survival of 11.4 months; P ¼ 0.003). Although most patients died within a few months, those few who were alive beyond 2 years in this cohort intriguingly experienced long-term survival.
In summary, adenosquamous carcinomas/squamous cell carcinomas of gallbladder are uncommon, together constituting B5% of the malignancies of this organ. They are often fairly advanced (pT2, pT3 and pT4) cancers at the time of diagnosis, and their prognosis is dismal if not more so than that of ordinary gallbladder adenocarcinomas. More studies are needed to determine the etiopathogenetic and molecular differences, if any, of this histologic type compared with conventional adenocarcinomas.
